Casana Receives FDA Clearance for Heart Health Smart Toilet Seat

Casana announced receipt of U.S.A. Food and Drug Administration (FDA) clearance of the Heart Seat™ for measuring Heart Rate and Oxygen Saturation (SpO2). The clearance marks a significant milestone for Casana in its pursuit to enable effortless home health monitoring.

Alongside Heart Rate and Oxygen Saturation (SpO2), Casana has partnered with researchers to conduct validation studies of additional clinical measurements. The company plans to file future indications this year, including Systolic and Diastolic Blood Pressure (BP), with the target of an initial product market launch by the end of 2023.

Casana通過批准Heart Seat™智能馬桶監測心臟健康用於測量心率的 和氧飽和度 (SpO2)。除了心率和氧飽和度 (SpO2)，Casana 還與研究人員合作，對其他臨床測量進行驗證研究。該公司計劃在今年提交未來適應症，包括收縮壓和舒張壓（BP），目標是在 2023 年底之前將初始產品投放市場。